Studies have shown the popular weight loss drugs known as GLP-1 agonists may be helpful for more than just curbing appetite — and new research is looking at their potential impact on cancer risk.

A new study found that GLP-1 drugs significantly reduce cancer risk associated with obesity — even more so than getting weight loss surgery. REUTERS Published in the Lancet’s eClinicalMedicine ...

The TRIM-EBC clinical trial, conducted through the Baylor Scott & White Research Institute, is studying whether weight loss drug Zepbound® (tirzepatide) can lower the risk of breast cancer ...

So the, the question we're investigating in this study is whether the use of GLP-1 receptor agonists, which is *** medication for weight loss and diabetes ... risk of cancer with the GOP1 receptor ...

“This is a call to scientists and clinical investigators to do more work in this area to really prove or disprove this,” said Dr. Ernest Hawk of MD Anderson Cancer Center in Houston, who was ...